Home
Zealand Pharma A/S

Zealand Pharma A/S Market Share Analysis for July 2026

Zealand Pharma is a biotechnology company dedicated to developing innovative peptide-based medicines for people living with unmet medical needs

Health > Biotechnology and Pharmaceuticals

Domainzealandpharma.com

Year Founded1998

Employees201 - 500

Annual Revenue$25M - $50M

Zealand Pharma A/S

Zealand Pharma A/S (including company regionals)

zealandpharma.com

See more website traffic and engagement information

Zealand Pharma A/S Revenue up to July 2026 is 25M - 50M

revenue generated by Zealand Pharma A/S top domains

Zealand Pharma A/S top domains revenue over 3 years

Revenue for Zealand Pharma A/S top domains

zealandpharma.com25M - 50M

See more with Sales Intelligence

Total visits to Zealand Pharma A/S's top domains

Understand Zealand Pharma A/S market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

zealandpharma.com25.7K

See more with Sales Intelligence

Avg. visit duration in Zealand Pharma A/S's top domains

Analyze Zealand Pharma A/S engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

zealandpharma.com00:00:26

See more with Sales Intelligence

Avg. pageviews on Zealand Pharma A/S's top domains

See how Zealand Pharma A/S keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

zealandpharma.com2.21

See more with Sales Intelligence

Zealand Pharma A/S top competitors by domain

Top similar sites in July 2026, ranked by their affinity

roche.comCompany NameRocheEmployees> 10001HQSwitzerlandAnnual revenue> $1BTotal visits1.7MHealth > Biotechnology and Pharmaceuticals

Top technologies used by Zealand Pharma A/S

These are the website technologies, by industry, used by Zealand Pharma A/S top domains

Marketing (5)

Google Marketing Platform

Email Services (4)

G Suite

Widget (4)

reCAPTCHA

Content Management System (3)

WordPress

More Technologies

11

See all

News & Signals from Zealand Pharma A/S

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsZealand Pharma partnered with Royalty Pharma on Jul 1st '18.While the FDA considers whether to approve Takeda and Protagonist Therapeutics' rusfertide, Zealand Pharma has monetized its remaining economic interest in the blood cancer treatment through a $100 million agreement with Royalty Pharma.

NewsZealand Pharma received financing of $100M on Aug 13th '26.Under the terms of the royalty purchase and sale agreement, Zealand Pharma will receive USD 100 million for the sale of its economic interests related to rusfertide, including rights to one percent royalty on potential future global net sales of rusfertide and regulatory and commercial milestones.